JPWO2023210657A1 - - Google Patents

Info

Publication number
JPWO2023210657A1
JPWO2023210657A1 JP2024517354A JP2024517354A JPWO2023210657A1 JP WO2023210657 A1 JPWO2023210657 A1 JP WO2023210657A1 JP 2024517354 A JP2024517354 A JP 2024517354A JP 2024517354 A JP2024517354 A JP 2024517354A JP WO2023210657 A1 JPWO2023210657 A1 JP WO2023210657A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024517354A
Other languages
Japanese (ja)
Other versions
JPWO2023210657A5 (https=
JP7713267B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023210657A1 publication Critical patent/JPWO2023210657A1/ja
Publication of JPWO2023210657A5 publication Critical patent/JPWO2023210657A5/ja
Priority to JP2025114296A priority Critical patent/JP7808901B2/ja
Application granted granted Critical
Publication of JP7713267B2 publication Critical patent/JP7713267B2/ja
Priority to JP2026003169A priority patent/JP2026063064A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024517354A 2022-04-26 2023-04-25 近視を予防または治療するための方法および組成物 Active JP7713267B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2025114296A JP7808901B2 (ja) 2022-04-26 2025-07-07 近視を予防または治療するための方法および組成物
JP2026003169A JP2026063064A (ja) 2022-04-26 2026-01-13 近視を予防または治療するための方法および組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022072596 2022-04-26
JP2022072596 2022-04-26
PCT/JP2023/016344 WO2023210657A1 (ja) 2022-04-26 2023-04-25 近視を予防または治療するための方法および組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025114296A Division JP7808901B2 (ja) 2022-04-26 2025-07-07 近視を予防または治療するための方法および組成物

Publications (3)

Publication Number Publication Date
JPWO2023210657A1 true JPWO2023210657A1 (https=) 2023-11-02
JPWO2023210657A5 JPWO2023210657A5 (https=) 2024-11-25
JP7713267B2 JP7713267B2 (ja) 2025-07-25

Family

ID=88519036

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2024517354A Active JP7713267B2 (ja) 2022-04-26 2023-04-25 近視を予防または治療するための方法および組成物
JP2025114296A Active JP7808901B2 (ja) 2022-04-26 2025-07-07 近視を予防または治療するための方法および組成物
JP2026003169A Pending JP2026063064A (ja) 2022-04-26 2026-01-13 近視を予防または治療するための方法および組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2025114296A Active JP7808901B2 (ja) 2022-04-26 2025-07-07 近視を予防または治療するための方法および組成物
JP2026003169A Pending JP2026063064A (ja) 2022-04-26 2026-01-13 近視を予防または治療するための方法および組成物

Country Status (9)

Country Link
EP (1) EP4516305A4 (https=)
JP (3) JP7713267B2 (https=)
KR (1) KR20250006145A (https=)
CN (1) CN119072322A (https=)
AU (1) AU2023258808A1 (https=)
CA (1) CA3249939A1 (https=)
MX (1) MX2024013133A (https=)
TW (1) TW202400198A (https=)
WO (1) WO2023210657A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025089394A1 (ja) * 2023-10-25 2025-05-01 株式会社坪田ラボ 近視を予防または治療するための方法および組成物
JP7781461B2 (ja) 2023-10-25 2025-12-08 株式会社坪田ラボ 近視を予防または治療するための方法および組成物
WO2025192737A1 (ja) * 2024-03-15 2025-09-18 株式会社坪田ラボ 脈絡膜菲薄化抑制剤

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107372821A (zh) * 2017-07-25 2017-11-24 芜湖职业技术学院 护眼保健酸奶及其制备方法
JP2018043986A (ja) * 2016-09-09 2018-03-22 学校法人慶應義塾 眼疲労の抑制又は改善用組成物
CN112493318A (zh) * 2020-12-01 2021-03-16 河北三元食品有限公司 一种专用于三周岁以上儿童的全营养奶粉及其制备方法
CN113349257A (zh) * 2021-04-13 2021-09-07 石家庄君乐宝乳业有限公司 一种有益于视力保护的发酵乳及其制备方法
WO2022065848A1 (ko) * 2020-09-23 2022-03-31 피비엘바이오랩 주식회사 신규 유산균 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3066561B2 (ja) * 1993-10-07 2000-07-17 武田薬品工業株式会社 近視予防・治療剤
TWI658828B (zh) * 2014-10-31 2019-05-11 中國醫藥大學 用於舒緩及減輕近視之醫藥組合物及其製備方法與用途
WO2018164113A1 (ja) * 2017-03-06 2018-09-13 学校法人 慶應義塾 マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤
JP7394737B2 (ja) 2020-10-30 2023-12-08 愛三工業株式会社 燃料供給装置

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018043986A (ja) * 2016-09-09 2018-03-22 学校法人慶應義塾 眼疲労の抑制又は改善用組成物
CN107372821A (zh) * 2017-07-25 2017-11-24 芜湖职业技术学院 护眼保健酸奶及其制备方法
WO2022065848A1 (ko) * 2020-09-23 2022-03-31 피비엘바이오랩 주식회사 신규 유산균 및 이의 용도
CN112493318A (zh) * 2020-12-01 2021-03-16 河北三元食品有限公司 一种专用于三周岁以上儿童的全营养奶粉及其制备方法
CN113349257A (zh) * 2021-04-13 2021-09-07 石家庄君乐宝乳业有限公司 一种有益于视力保护的发酵乳及其制备方法

Also Published As

Publication number Publication date
MX2024013133A (es) 2024-12-06
JP7808901B2 (ja) 2026-01-30
KR20250006145A (ko) 2025-01-10
CN119072322A (zh) 2024-12-03
JP2025129384A (ja) 2025-09-04
EP4516305A4 (en) 2026-04-08
WO2023210657A1 (ja) 2023-11-02
EP4516305A1 (en) 2025-03-05
CA3249939A1 (en) 2025-06-17
JP7713267B2 (ja) 2025-07-25
AU2023258808A1 (en) 2024-11-07
JP2026063064A (ja) 2026-04-10
TW202400198A (zh) 2024-01-01

Similar Documents

Publication Publication Date Title
JPWO2023210657A1 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001987A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR102022017795A2 (https=)
BR202022000931U2 (https=)
CN307044965S (https=)
CN307048019S (https=)
BY13166U (https=)
BY13165U (https=)
BY13164U (https=)
BY13163U (https=)
BY13162U (https=)
BY13161U (https=)
CN306977746S9 (https=)
BY13160U (https=)
CN307044792S (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241108

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241108

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20241108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241202

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250328

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250610

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250707

R150 Certificate of patent or registration of utility model

Ref document number: 7713267

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150